Baijin Life Science (HKG:1466) booked HK$1.5 million in attributable loss for the year ended March 31, narrowing from a loss of HK$9.5 million a year earlier, according to a Hong Kong bourse filing Friday.
Shares of the jewelry maker jumped over 4% in afternoon trade Monday.
Basic loss per share stood at HK$0.0005 compared to HK$0.0115 a year prior.
The company generated HK$135.6 million in revenue for the year, up from HK$53.7 million in the earlier fiscal year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.